These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36012838)

  • 1. COVID-19-Associated Pulmonary Fungal Infection among Pediatric Cancer Patients, a Single Center Experience.
    Madney Y; Shalaby L; Hammad M; Elanany M; Hassan R; Youssef A; Abdo I; Zaki A; Khedr R
    J Fungi (Basel); 2022 Aug; 8(8):. PubMed ID: 36012838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
    Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J
    Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.
    Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT;
    J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020-March 2021.
    Sivasubramanian G; Ghanem H; Maison-Fomotar M; Jain R; Libke R
    J Fungi (Basel); 2021 Nov; 7(11):. PubMed ID: 34829235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
    Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
    Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea.
    Kim JH; Kim M; Lim S; Park SY; Jegal Y; Lee T; Kang BJ
    Acute Crit Care; 2023 Aug; 38(3):382-388. PubMed ID: 35791656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case-Control Study.
    Calderón-Parra J; Moreno-Torres V; Mills-Sanchez P; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A
    J Fungi (Basel); 2022 Feb; 8(2):. PubMed ID: 35205914
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
    Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
    J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study.
    Melchers M; van Zanten ARH; Heusinkveld M; Leeuwis JW; Schellaars R; Lammers HJW; Kreemer FJ; Haas PJ; Verweij PE; van Bree SHW
    Crit Care Explor; 2022 May; 4(5):e0696. PubMed ID: 35558738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography.
    Baratella E; Roman-Pognuz E; Zerbato V; Minelli P; Cavallaro MFM; Cova MA; Luzzati R; Lucangelo U; Sanson G; Friso F; Bussani R; Pinamonti M; Busetti M; Salton F; Confalonieri M; Ruaro B; Di Bella S
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1607-1612. PubMed ID: 34994174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008-2013.
    Chen CY; Sheng WH; Tien FM; Lee PC; Huang SY; Tang JL; Tsay W; Tien HF; Hsueh PR
    J Microbiol Immunol Infect; 2020 Feb; 53(1):106-114. PubMed ID: 29449166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis.
    Hawes AM; Permpalung N
    Antibiotics (Basel); 2022 Nov; 11(12):. PubMed ID: 36551361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico.
    Roman-Montes CM; Bojorges-Aguilar S; Corral-Herrera EA; Rangel-Cordero A; Díaz-Lomelí P; Cervantes-Sanchez A; Martinez-Guerra BA; Rajme-López S; Tamez-Torres KM; Martínez-Gamboa RA; González-Lara MF; Ponce-de-Leon A; Sifuentes-Osornio J
    J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233294
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19-Associated Pulmonary Aspergillosis in Russia.
    Shadrivova O; Gusev D; Vashukova M; Lobzin D; Gusarov V; Zamyatin M; Zavrazhnov A; Mitichkin M; Borzova Y; Kozlova O; Desyatik E; Burygina E; Ignatyeva S; Oganesyan E; Vasilyeva N; Klimko N; Working Group
    J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
    Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
    Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
    Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
    Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
    Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
    J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isavuconazole for COVID-19-Associated Invasive Mold Infections.
    Ullah N; Sepulcri C; Mikulska M
    J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.